47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
72.11.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 47,8 | |||
Gross profit (loss) | -0,6 | -0,6 | -0,3 | 45,5 |
EBITDA | -0,5 | -0,5 | -0,3 | 44,5 |
Short time liabilities | 0,8 | 1,4 | 1,3 | -7,2 |
Other operating costs | 95,4 | |||
Equity capital | 0,6 | 0 | -0,2 | -14 401,6 |
Operating profit (EBIT) | -0,5 | -0,5 | -0,3 | 44,7 |
Assets | 1,7 | 1,8 | 1,7 | -5,2 |
Net profit (loss) | -0,6 | -0,6 | -0,3 | 45,5 |
Cash | 0,9 | 0,8 | 0,3 | -58,4 |
Liabilities and provisions for liabilities | 1,1 | 1,8 | 1,8 | 5,1 |
Net income from sale | 0,6 | 3,9 | 6 | 53,7 |
Working assets | 1,6 | 1,7 | 1,6 | -4,8 |
Other income costs | 112,6 | |||
Depreciation | 0 | 0 | 0 | -51,3 |
% | % | % | p.p. | |
Profitability of capital | -103,4 | -44 760,3 | 170,4 | 44 930,7 |
Equity capital to total assets | 32,9 | 0,1 | -10,7 | -10,8 |
Gross profit margin | -95,6 | -14,3 | -5,1 | 9,2 |
EBITDA Margin | -76,7 | -13,5 | -4,9 | 8,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 460 | 126 | 76 | -50 |
Current financial liquidity indicator | -0,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane